Home > Packaging > Industrial Packaging > Pharmaceutical Packaging > Parenteral Packaging Market

Parenteral Packaging Market - By Packaging (Vials, Cartridges, Ampoules, Prefilled Syringes, Infusion Solutions Bottles, Infusion Solutions Bags, Containers, Others), By Material (Glass, Polymers), By Region & Global Forecast, 2023 – 2032

  • Report ID: GMI5389
  • Published Date: Apr 2023
  • Report Format: PDF

Parenteral Packaging Market Size

Parenteral Packaging Market size was over USD 30 billion in 2022. Given the increased requirement for medical treatments among the growing geriatric population, the industry is poised to depict more than 6% CAGR through 2023-2032.
 

Parenteral Packaging Market

The number of elderly people continues to grow worldwide. In European countries, the average life expectancy was over 75 years in 2010 and is expected to rise to over 80 years through the next decade, which can be credited to the advancement in medical practices. The need for the diagnosis and management of geriatric medical problems will therefore rise, augmenting the demand for cartridges, ampoules, and other parenteral products.
 

Vaccinations are a major health intervention that has a significant positive effect on the health of the population. Immunization has a significant correlation with parenteral demand. Accreditation plans such as the Global Vaccine Action Plan (GVAP) and the National Vaccine Plan (NVP) by the United States, which are introduced by the government on a regular basis to eradicate health issues such as hepatitis, polio, and others, are anticipated to fuel the parenteral packaging market further.
 

 

Supply and demand variations due to fluctuating costs of raw materials such as polymers and glass are, however, impacting the sales of parenteral package solutions globally. In addition, downward pressure on prices amid strong competition from multinational manufacturers is creating a hindrance to industry expansion. Despite these challenges, the mounting usage of injectable pharmaceuticals may lead to a recovery in cartridge production, fueling parenteral packaging industry growth over the estimated timeline.
 

Parenteral Packaging Market Analysis

In terms of packaging, parenteral packaging market value from the vials segment is anticipated to be worth over USD 6 billion by 2032. In the healthcare industry, vials are tiny containers or bottles made of glass or plastic. They are used as vials to keep medications in liquid form, but they may also hold tablets and powders. They are often bigger containers used to transport numerous medication dosages. Vials are sealed with a rubber plug or a screw on a cap, allowing them to be resealed & reopened. The demand for vials is expanding internationally owing to the expansion of the pharmaceutical sector. The pharmaceutical sector around the world is increasing due to rising therapeutical diseases.
 

 

Based on material, the parenteral packaging market is categorized into glass and polymers. The industry share from the glass segment is poised to depict a 7% CAGR through 2023-2032. Glass is primarily used in the production of vials, cartridges, ampoules, prefilled syringes, containers, bags, flasks, and other items. Because of its impermeable and non-porous character, as well as the ability to maintain product composition, it is one of the most used raw materials in parenteral packaging. Glass also shields goods from UV rays, extending product shelf life. The widespread use of generic injectable drugs, combined with high demand from the pharmaceutical industry.
 

 

Asia Pacific parenteral packaging market is projected to reach over USD 27.5 billion by 2032. The rising emphasis on the creation of sustainable and biodegradable packaging solutions and the advancement in manufacturing processes are among the key growth drivers. Over the years, there has been an increase in investments in R&D projects to innovate packaging technologies. Initiatives such as these will stimulate the development of efficient parenteral packaging materials in the region. APAC is also home to some of the biggest healthcare markets in the world, indicating the significant potential for the industry.
 

Technological advancements, manufacturing processes, and innovations in parenteral packaging across companies have resulted in rapid industry growth. Chemotherapy medicines administered intravenously are frequently utilized to treat cancer. The demand for these medications has grown significantly over time because of the growing prevalence of cancer in the region. However, they must be packed properly to preserve the potency of the pharmaceutical components in the medications, which is predicted to fuel the expansion of the parenteral packaging market during the forecast period.
 

Parenteral Packaging Market Share

  • Becton
  • Dickinson and Company (BD)
  • Schott AG
  • Gerresheimer AG
  • Nipro Corporation
  • Ypsomed Holding AG
  • West Pharmaceutical Services Inc
  • Baxter International Inc
  • Terumo Corporation
  • Stevanato Group S.p.A
  • Corning Inc
  • Catalent Inc.,
  • Sio2 Materials Science

are some of the prominent players in the parenteral packaging industry. These firms are focusing on strategies such as manufacturing capacity expansion to boost their customer base and reinforce their presence in the market.
 

Impact of COVID-19 Pandemic

Immunization and vaccination became essential health activities during the COVID-19 pandemic. Since vaccinations against potential variants of the virus have become a top priority, the sales of vials and glass tubes have soared, especially in the U.S. and Europe markets. The introduction of immunization campaigns has also encouraged ampoules producers to operate at breakneck rates to address the burgeoning vaccine demand. The escalating consumption of sterilized glass syringes for bio-pharma drugs will thus support parenteral packaging material developers, even in the post-pandemic era.
 

The parenteral packaging market research report includes in-depth coverage of the industry with estimates & forecast in terms of volume in kilo tons and revenue in USD million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report


By Packaging Type

  • Vials
  • Cartridges
  • Ampoules
  • Prefilled syringes
  • Infusion solutions bottles
  • Infusion solutions bags
  • Containers
  • Others

By Material

  • Glass
  • Polymers

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Russia
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • Indonesia
    • Malaysia
    • Vietnam
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa

 

Authors: Kiran Pulidindi, Hiralkumar Patel

Frequently Asked Questions (FAQ) :

The market size for parenteral packaging reached over USD 30 billion in 2022 and is poised to exhibit more than a 6% CAGR through 2023-2032, due to the rising number of geriatric people susceptible to medical conditions.

Parenteral packaging industry share from the glass material segment is poised to depict a 7% CAGR through 2023-2032, owing to UV protection, enhanced shelf life, non-porous nature, and other advantages.

APAC parenteral packaging industry size is projected to reach over USD 27.5 billion by 2032, given the high emphasis on the development of sustainable and biodegradable packaging solutions.

Key players in the parenteral packaging industry include Schott AG, Gerresheimer AG, Nipro Corporation, Ypsomed Holding AG, Baxter International Inc., Terumo Corporation, Catalent, Inc., and Sio2 Materials Science, among others.

Parenteral Packaging Market Scope

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2022
  • Companies covered: 12
  • Tables & Figures: 309
  • Countries covered: 20
  • Pages: 275
 Download Free Sample